NMC
OREX
NEA Management Company’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q1 | – | Sell |
-370,900
| Closed | -$478K | – | 46 |
|
2017
Q4 | $478K | Hold |
370,900
| – | – | 0.02% | 43 |
|
2017
Q3 | $786K | Hold |
370,900
| – | – | 0.03% | 41 |
|
2017
Q2 | $1.08M | Hold |
370,900
| – | – | 0.04% | 42 |
|
2017
Q1 | $1.28M | Hold |
370,900
| – | – | 0.04% | 35 |
|
2016
Q4 | $645K | Hold |
370,900
| – | – | 0.03% | 37 |
|
2016
Q3 | $1.23M | Hold |
370,900
| – | – | 0.06% | 36 |
|
2016
Q2 | $1.6M | Sell |
370,900
-3,338,100
| -90% | -$14.4M | 0.08% | 35 |
|
2016
Q1 | $2.08M | Hold |
3,709,000
| – | – | 0.14% | 34 |
|
2015
Q4 | $6.38M | Hold |
3,709,000
| – | – | 0.41% | 23 |
|
2015
Q3 | $7.83M | Hold |
3,709,000
| – | – | 0.52% | 24 |
|
2015
Q2 | $18.4M | Hold |
3,709,000
| – | – | 0.96% | 19 |
|
2015
Q1 | $29M | Hold |
3,709,000
| – | – | 1.31% | 16 |
|
2014
Q4 | $22.5M | Hold |
3,709,000
| – | – | 1.09% | 20 |
|
2014
Q3 | $15.8M | Buy |
3,709,000
+1,773,700
| +92% | +$7.56M | 0.8% | 23 |
|
2014
Q2 | $12M | Hold |
1,935,300
| – | – | 0.56% | 25 |
|
2014
Q1 | $12.6M | Hold |
1,935,300
| – | – | 0.62% | 23 |
|
2013
Q4 | $10.9M | Buy |
1,935,300
+780,000
| +68% | +$4.39M | 0.53% | 23 |
|
2013
Q3 | $7.08M | Buy |
+1,155,300
| New | +$7.08M | 0.28% | 27 |
|